ENVERIC BIOSCIENCES, INC. Noncash or Part Noncash Acquisition, Payables Assumed
ENVERIC BIOSCIENCES, INC. (ENVB) reported Noncash or Part Noncash Acquisition, Payables Assumed of $2.90 million for the 12-month period ending 2016-12-31, per its 10-K/A filed 2017-04-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1 · last filed 2017-04-04
- ENVERIC BIOSCIENCES, INC. noncash or part noncash acquisition, payables assumed for the quarter ending 2016-12-31 was -$5.88M, a 153.59% decline year-over-year.
- ENVERIC BIOSCIENCES, INC. noncash or part noncash acquisition, payables assumed for the quarter ending 2016-09-30 was $5.55M.
- ENVERIC BIOSCIENCES, INC. noncash or part noncash acquisition, payables assumed for the quarter ending 2016-06-30 was $4.95M, a 2376.26% increase year-over-year.
- ENVERIC BIOSCIENCES, INC. noncash or part noncash acquisition, payables assumed for the quarter ending 2016-03-31 was -$1.72M.
- ENVERIC BIOSCIENCES, INC. noncash or part noncash acquisition, payables assumed for fiscal 2016 was $2.90M, a 64.43% increase from fiscal 2015.
- ENVERIC BIOSCIENCES, INC. noncash or part noncash acquisition, payables assumed for fiscal 2015 was $1.77M.
| Period end | Noncash or Part Noncash Acquisition, Payables Assumed 3 month | Noncash or Part Noncash Acquisition, Payables Assumed 6 month | Noncash or Part Noncash Acquisition, Payables Assumed 9 month | Noncash or Part Noncash Acquisition, Payables Assumed 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$5.88M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-04-04 | -$329.10K derived: sum of 2 quarters · filed 2017-04-04 | $4.62M derived: sum of 3 quarters · filed 2017-04-04 | $2.90M 10-K/A · filed 2017-04-04 |
| 2016-09-30 | $5.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $10.50M derived: sum of 2 quarters · filed 2016-11-14 | $8.78M 10-Q · filed 2016-11-14 | $19.74M derived: sum of 4 quarters · filed 2017-04-04 |
| 2016-06-30 | $4.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $3.23M 10-Q · filed 2016-08-12 | $14.20M derived: sum of 3 quarters · filed 2017-04-04 | $4.90M derived: sum of 4 quarters · filed 2017-04-04 |
| 2016-03-31 | -$1.72M 10-Q · filed 2016-05-16 | $9.25M derived: sum of 2 quarters · filed 2017-04-04 | -$53.16K derived: sum of 3 quarters · filed 2017-04-04 | $146.77K derived: sum of 4 quarters · filed 2017-04-04 |
| 2015-12-31 | $10.97M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-04-04 | $1.67M derived: sum of 2 quarters · filed 2017-04-04 | $1.87M derived: sum of 3 quarters · filed 2017-04-04 | $1.77M 10-K/A · filed 2017-04-04 |
| 2015-09-30 | -$9.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$9.10M derived: sum of 2 quarters · filed 2016-11-14 | -$9.20M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $199.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $99.94K 10-Q · filed 2016-08-12 | ||
| 2015-03-31 | -$100.00K 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |